G Tu, Y Gong, X Yao, Q Liu,
W Xue, R Zhang - International Journal of …, 2024 - Elsevier
Abstract KRAS G12D is the most common oncogenic mutation identified in several types of
cancer. Therefore, design of inhibitors targeting KRAS G12D represents a promising …